Florida State University, Department of Psychology
Tallahassee, Florida, 32306, United States
NCT Number: NCT02413814
Problematic anger is a strong predictor of failed attempts at smoking cessation. The investigators proposed study seeks to evaluate whether a novel 8-session computerized anger-reduction treatment improves quit rates among smokers. Smokers with elevated trait anger will be administered transdermal nicotine patch therapy and either anger-reduction treatment or a control intervention. They will be assessed throughout treatment and up until three months after a scheduled mid- treatment quit date. The investigators propose to test whether, compared to the control condition, the anger-reduction treatment will lead to: 1) greater reductions in anger and 2) greater abstinence rates at post-cessation and at follow-up assessments. The investigators will also test whether changes in anger-related symptoms account for group differences in abstinence rates.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Tallahassee, Florida, 32306, United States
The current proposal seeks to evaluate an eight-session, computerized, anger-focused intervention for smokers (Anger Reduction Treatment or ART). The investigators will administer this intervention to smokers (N = 114) who are interested in quitting and have elevated levels of trait anger. Participants will be randomly assigned to receive either: (1) computerized ART, consisting of interpretation bias modification, or (2) a computerized control condition, which consists of health education and relaxing video clips. The computerized sessions (eight total) will take place twice a week for four weeks. All participants will have a scheduled quit date for the beginning of the third week of treatment (i.e., at mid-treatment). All participants will also receive nicotine patch therapy to use at their scheduled quit date. Anger symptoms, smoking cravings, and smoking frequency will be assessed throughout treatment. Smoking status, anger, and other measures of negative affect will also be assessed at baseline and regularly for 12-weeks following the scheduled quit date.
The investigators will test whether, compared to the control condition, the anger-reduction treatment will lead to: 1) greater reductions in anger and 2) greater abstinence rates at post-cessation and at follow-up assessments. The investigators will also test whether changes in anger-related symptoms account for group differences in abstinence rates.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eight 30-minute sessions of interpretation modification to reduce angry interpretation biases.
Eight 30-minute sessions of informative videos on healthy living and relaxation videos.
Time frame: up to 14-weeks following treatment initiation.
Time frame: up to 14-weeks following treatment initiation.
Time frame: up to 14-weeks following treatment initiation.
Time frame: up to 14-weeks following treatment initiation.
Time frame: Baseline and regularly for 14-weeks following treatment initiation.
Time frame: up to 14-weeks following treatment initiation.
Time frame: up to 14-weeks following treatment initiation.
Time frame: up to 14-weeks following treatment initiation
Time frame: up to 14-weeks following treatment initiation.
Florida State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04654260
Aberrant Motor Behavior in Dementia, Aggression
New Haven, Connecticut, United States
View Trial DetailsNCT07603986
Anger, Behavior
Petah Tikva, Israel
View Trial DetailsNCT02882802
Aberrant Motor Behavior in Dementia, Aggression
West Haven, Connecticut, United States
View Trial DetailsNCT07496268
Anger, Art Therapy
Istanbul, Kartal, Turkey (Türkiye)
View Trial Details